Riyam Hassan Tuama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Riyam Hassan Tuama has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Safaa Ehssan Atta
Continuing Education Center, Mustansiriyah University
2 shared publications - Dhuha Badr Mahmood
National Diabetes Center, Mustansiriyah University
1 shared publication - Ghufran Salman Jawad
National Diabetes Center, Mustansiriyah University
1 shared publication - Hala Fouad Kasim
DEPARTMENT OF BIOLOGY MUSTANSIRIYAH UNIVERSITY BAGHDAD IRAQ
1 shared publication - Hanan Ibrahim Abdulwahid
National Diabetes Center, Mustansiriyah University
1 shared publication - Jihad Anad Khalaf
College of Medicine, Al-Iraqia University
1 shared publication
Latest Publications
- Open Access
- 29 October 2026
- Published by Kuban State Medical University in Kuban Scientific Medical Bulletin
- Vol. 33 (5) , 78-87
Exploring essential oils and propolis as adjuncts or alternatives to azole antifungals for Candida infections: Laboratory experimental study
Background. Fungal infections caused by Candida species represent a significant and growing threat to human health, particularly among immunocompromised individuals, such as those undergoing chemotherapy, organ transplant recipients, and patients in intensive care units. These opportunistic pathogens are responsible for a wide spectrum of clinical manifestations, ranging from superficial mucosal infections to life-threatening invasive candidiasis. The increasing resistance of Candida spp. to conventional antifungal agents, especially the azoles, has prompted the scientific community to explore alternative therapeutic options, including natural products. Essential oils derived from plants of the Lamiaceae family and propolis, a resinous substance produced by honeybees, have emerged as promising candidates due to their diverse bioactive compounds and broad-spectrum antimicrobial properties. Objective. the primary objective of this study was to evaluate the in vitro susceptibility of clinical Candida isolates to both conventional azole antifungals and plant-derived agents, and to assess their ability to inhibit biofilm formation. Methods. A total of fifty clinical Candida isolates were obtained from urine samples and identified using PCR with standard species-specific primers and MALDI-TOF mass spectrometry, following the manufacturer’s protocols. The study employed two main experimental approaches: the disk diffusion method to assess antifungal activity against planktonic cells, and a static microtiter biofilm assay to evaluate antibiofilm effects. The agents tested included marjoram oil, sage oil, thyme oil, and propolis, while the conventional antifungals used for comparison were clotrimazole (10 µg), itraconazole (10 µg), and fluconazole (25 µg). Biofilm inhibition was calculated based on optical density measurements at 570 nm (OD₅₇₀). Results. Propolis exhibited the highest antifungal activity among the natural products tested. Its inhibition zones measured 20.46 ± 2.87 mm against C. glabrata and 21.70 ± 1.16 mm against C . parapsilosis . Marjoram oil followed, with zones of 16.11 ± 1.48 mm and 15.50 ± 0.85 mm, respectively, while sage oil showed moderate activity (11.56 ± 1.56 mm and 10.90 ± 1.20 mm). Thyme oil produced no inhibition zones against either species, indicating a lack of activity in the disk diffusion assay. Among the conventional antifungals, clotrimazole was the most effective against C. glabrata (23.96 ± 6.41 mm), whereas against C. parapsilosis , propolis surpassed clotrimazole, with an inhibition zone of 21.70 mm compared to 13.80 mm for clotrimazole. In terms of biofilm inhibition, propolis again demonstrated the strongest effect, reducing biofilm formation by 44.9% in C. glabrata and 41.2% in C. parapsilosis . Marjoram oil inhibited biofilm formation by 33.9% and 28.6%, sage oil by 24.6% and 19.3%, and thyme oil by 19.5% and 39.5%, respectively. Interestingly, thyme oil, despite being inactive in the disk diffusion test, showed a notable species-dependent antibiofilm effect, particularly against C. parapsilosis . Conclusion. Propolis and marjoram oil demonstrate promising antifungal and antibiofilm activity against C. glabrata and C. parapsilosis . Thyme oil is inactive in disk diffusion but exhibits species-dependent antibiofilm effects. Clotrimazole remains highly active against C. glabrata , but propolis may be superior against C. parapsilosis . These findings suggest that natural agents warrant further investigation as adjuncts or alternatives to conventional azole antifungals, particularly in cases of azole-resistant Candida infections.
- 29 October 2026
- Published by Kuban State Medical University in Kuban Scientific Medical Bulletin
- Vol. 33 (5) , 78-87
Open AccessExploring essential oils and propolis as adjuncts or alternatives to azole antifungals for Candida infections: Laboratory experimental study
Background. Fungal infections caused by Candida species represent a significant and growing threat to human health, particularly among immunocompromised individuals, such as those undergoing chemotherapy, organ transplant recipients, and patients in intensive care units. These opportunistic pathogens are responsible for a wide spectrum of clinical manifestations, ranging from superficial mucosal infections to life-threatening invasive candidiasis. The increasing resistance of Candida spp. to conventional antifungal agents, especially the azoles, has prompted the scientific community to explore alternative therapeutic options, including natural products. Essential oils derived from plants of the Lamiaceae family and propolis, a resinous substance produced by honeybees, have emerged as promising candidates due to their diverse bioactive compounds and broad-spectrum antimicrobial properties. Objective. the primary objective of this study was to evaluate the in vitro susceptibility of clinical Candida isolates to both conventional azole antifungals and plant-derived agents, and to assess their ability to inhibit biofilm formation. Methods. A total of fifty clinical Candida isolates were obtained from urine samples and identified using PCR with standard species-specific primers and MALDI-TOF mass spectrometry, following the manufacturer’s protocols. The study employed two main experimental approaches: the disk diffusion method to assess antifungal activity against planktonic cells, and a static microtiter biofilm assay to evaluate antibiofilm effects. The agents tested included marjoram oil, sage oil, thyme oil, and propolis, while the conventional antifungals used for comparison were clotrimazole (10 µg), itraconazole (10 µg), and fluconazole (25 µg). Biofilm inhibition was calculated based on optical density measurements at 570 nm (OD₅₇₀). Results. Propolis exhibited the highest antifungal activity among the natural products tested. Its inhibition zones measured 20.46 ± 2.87 mm against C. glabrata and 21.70 ± 1.16 mm against C . parapsilosis . Marjoram oil followed, with zones of 16.11 ± 1.48 mm and 15.50 ± 0.85 mm, respectively, while sage oil showed moderate activity (11.56 ± 1.56 mm and 10.90 ± 1.20 mm). Thyme oil produced no inhibition zones against either species, indicating a lack of activity in the disk diffusion assay. Among the conventional antifungals, clotrimazole was the most effective against C. glabrata (23.96 ± 6.41 mm), whereas against C. parapsilosis , propolis surpassed clotrimazole, with an inhibition zone of 21.70 mm compared to 13.80 mm for clotrimazole. In terms of biofilm inhibition, propolis again demonstrated the strongest effect, reducing biofilm formation by 44.9% in C. glabrata and 41.2% in C. parapsilosis . Marjoram oil inhibited biofilm formation by 33.9% and 28.6%, sage oil by 24.6% and 19.3%, and thyme oil by 19.5% and 39.5%, respectively. Interestingly, thyme oil, despite being inactive in the disk diffusion test, showed a notable species-dependent antibiofilm effect, particularly against C. parapsilosis . Conclusion. Propolis and marjoram oil demonstrate promising antifungal and antibiofilm activity against C. glabrata and C. parapsilosis . Thyme oil is inactive in disk diffusion but exhibits species-dependent antibiofilm effects. Clotrimazole remains highly active against C. glabrata , but propolis may be superior against C. parapsilosis . These findings suggest that natural agents warrant further investigation as adjuncts or alternatives to conventional azole antifungals, particularly in cases of azole-resistant Candida infections.
- Open Access
- 1 June 2026
- Published by Ivan Franko National University of Lviv in Studia Biologica
- Vol. 20 (2) , 81-96
Correlation between mutational profiles in fluoroquinolone resistance genes (gyrA and grlA) and phenotypic antibiotic susceptibility in clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA)
Background. Methicillin-resistant Staphylococcus aureus (MRSA) is recognized as a highly significant multidrug-resistant pathogen that can lead to severe fetal infections in both humans and animals. Fluoroquinolones (FQs) are considered among the antibiotics of choice used to manage MRSA infections. This study addresses rising fluoroquinolone resistance that limits treatment options. Resistance mechanisms typically involve mutations in the gyrA and grlA genes, which encode the drug’s targets. Objective: the aim of this research is to identify the genetic basis for resistance in clinical MRSA isolates. Specifically, the research focused on investigating the distribution of mutations in the gyrA and grlA genes responsible for fluoroquinolone resistance in MRSA isolates obtained from different clinical sources and assessing the correlation of these mutations with phenotypic antibiotic resistance. Materials and Methods. Fifty MRSA isolates collected from various clinical specimens (burn, wound, nose, throat, urine, skin, ear, and operating room samples) were used in the study. Bacteriological methods and PCR detection of the nuc gene confirmed the identification of the isolates. Then, all of the isolates were tested against seven different antibiotics (methicillin, ciprofloxacin, levofloxacin, norfloxacin, ofloxacin, lomefloxacin, and nalidixic acid) using the disk diffusion method and Minimum Inhibitory Concentration (MIC) tests. Twelve isolates exhibiting antibiotic resistance were selected for direct sequence analysis of the gyrA, grlA, and mecA gene regions. The relationship between mutations and resistance was analyzed statistically. Results. All isolates (100 %) carried the mecA gene, and no mutations were detected in this gene. The prevalence of fluoroquinolone resistance was 24 % (12 isolates). Sequence analysis revealed mutations at eight different positions in the gyrA gene (two missense, one deletion, and five silent) and seven different positions in the grlA gene (three missense, one silent, and three insertions). Statistical analysis revealed a significant positive correlation between mutant isolates in the gyrA and grlA genes and fluoroquinolone resistance (p < 0.0001). A significant correlation was also found between nalidixic acid resistance and the presence of mutations (p < 0.009). Conclusion. The findings of this study indicate that a major mechanism of fluoroquinolone resistance in clinical MRSA isolates is the accumulation of mutations in the gyrA and grlA genes, which encode target enzymes, and that these mutations are strongly associated with high-level phenotypic resistance. It has been confirmed that methicillin resistance Are rely to the presence of the mecA gene and does not require a mutation in the gene itself. These results provide deeper insight into the underlying mechanisms of antimicrobial resistance.
- 1 June 2026
- Published by Ivan Franko National University of Lviv in Studia Biologica
- Vol. 20 (2) , 81-96
Open AccessCorrelation between mutational profiles in fluoroquinolone resistance genes (gyrA and grlA) and phenotypic antibiotic susceptibility in clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA)
Background. Methicillin-resistant Staphylococcus aureus (MRSA) is recognized as a highly significant multidrug-resistant pathogen that can lead to severe fetal infections in both humans and animals. Fluoroquinolones (FQs) are considered among the antibiotics of choice used to manage MRSA infections. This study addresses rising fluoroquinolone resistance that limits treatment options. Resistance mechanisms typically involve mutations in the gyrA and grlA genes, which encode the drug’s targets. Objective: the aim of this research is to identify the genetic basis for resistance in clinical MRSA isolates. Specifically, the research focused on investigating the distribution of mutations in the gyrA and grlA genes responsible for fluoroquinolone resistance in MRSA isolates obtained from different clinical sources and assessing the correlation of these mutations with phenotypic antibiotic resistance. Materials and Methods. Fifty MRSA isolates collected from various clinical specimens (burn, wound, nose, throat, urine, skin, ear, and operating room samples) were used in the study. Bacteriological methods and PCR detection of the nuc gene confirmed the identification of the isolates. Then, all of the isolates were tested against seven different antibiotics (methicillin, ciprofloxacin, levofloxacin, norfloxacin, ofloxacin, lomefloxacin, and nalidixic acid) using the disk diffusion method and Minimum Inhibitory Concentration (MIC) tests. Twelve isolates exhibiting antibiotic resistance were selected for direct sequence analysis of the gyrA, grlA, and mecA gene regions. The relationship between mutations and resistance was analyzed statistically. Results. All isolates (100 %) carried the mecA gene, and no mutations were detected in this gene. The prevalence of fluoroquinolone resistance was 24 % (12 isolates). Sequence analysis revealed mutations at eight different positions in the gyrA gene (two missense, one deletion, and five silent) and seven different positions in the grlA gene (three missense, one silent, and three insertions). Statistical analysis revealed a significant positive correlation between mutant isolates in the gyrA and grlA genes and fluoroquinolone resistance (p < 0.0001). A significant correlation was also found between nalidixic acid resistance and the presence of mutations (p < 0.009). Conclusion. The findings of this study indicate that a major mechanism of fluoroquinolone resistance in clinical MRSA isolates is the accumulation of mutations in the gyrA and grlA genes, which encode target enzymes, and that these mutations are strongly associated with high-level phenotypic resistance. It has been confirmed that methicillin resistance Are rely to the presence of the mecA gene and does not require a mutation in the gene itself. These results provide deeper insight into the underlying mechanisms of antimicrobial resistance.
- 30 December 2025
- Published by ALUNA in Wiadomości Lekarskie
- No. 12,p. 2634-2641
Evaluation of Neopterin serum levels in type 2 diabetic patients with hypothyroidism
Aim: Background: Endocrine dysfunction is the source of both diabetes and thyroid disorders, and it has been shown that these conditions affect one another. Appropriate glycemic control can lower the occurrence of hypothyroidism, which is more common in T2DM patients. Neopterin is a sensitive indicator of infectious illnesses linked to heightened cellular immune system activity. Objectives: This study aim to investigate the variation in Neopterin serum levels between adult individuals (T2DM with hypothyroidism and without Hypothyroidism). Material and methods: Materials and methods: Ninety participants were divided into three group: (30) T2DM with Hypothyroidism patients, (30) T2DM without Hypothyroidism patients and (30) Control. They were obtained from national diabetes center, Mustansiriyah University. Results: Results: At P<0.001 a highly significant different increase of neopterin levels among three groups. The level of Neopterin in T2DM with Hypothyroidism patients, and T2DM without Hypothyroidism patients have a positive correlation coefficient with P<0.05 of the BMI, HbA1c, TC, TG, AIP and TSH. Furthermore, a positive correlation with P<0.01 to FBS, HOMA-IR and LDL-C. Conclusions: Conclusion: The elevated levels of neopterin in type 2 diabetic patients with hypothyroidism and without hypothyroidism play as a regulator of energy consumption, leading to the hypothesis that thyroid gland disease may influence its level. In addition, the potential for use as a diagnostic marker for diabetics with thyroid disease due to the occurrence of complications of diabetes, including cardiovascular diseases.
- 30 December 2025
- Published by ALUNA in Wiadomości Lekarskie
- No. 12,p. 2634-2641
Evaluation of Neopterin serum levels in type 2 diabetic patients with hypothyroidism
Aim: Background: Endocrine dysfunction is the source of both diabetes and thyroid disorders, and it has been shown that these conditions affect one another. Appropriate glycemic control can lower the occurrence of hypothyroidism, which is more common in T2DM patients. Neopterin is a sensitive indicator of infectious illnesses linked to heightened cellular immune system activity. Objectives: This study aim to investigate the variation in Neopterin serum levels between adult individuals (T2DM with hypothyroidism and without Hypothyroidism). Material and methods: Materials and methods: Ninety participants were divided into three group: (30) T2DM with Hypothyroidism patients, (30) T2DM without Hypothyroidism patients and (30) Control. They were obtained from national diabetes center, Mustansiriyah University. Results: Results: At P<0.001 a highly significant different increase of neopterin levels among three groups. The level of Neopterin in T2DM with Hypothyroidism patients, and T2DM without Hypothyroidism patients have a positive correlation coefficient with P<0.05 of the BMI, HbA1c, TC, TG, AIP and TSH. Furthermore, a positive correlation with P<0.01 to FBS, HOMA-IR and LDL-C. Conclusions: Conclusion: The elevated levels of neopterin in type 2 diabetic patients with hypothyroidism and without hypothyroidism play as a regulator of energy consumption, leading to the hypothesis that thyroid gland disease may influence its level. In addition, the potential for use as a diagnostic marker for diabetics with thyroid disease due to the occurrence of complications of diabetes, including cardiovascular diseases.